Glenmark Pharmaceuticals rises on incorporating wholly-owned subsidiary
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Glenmark Pharmaceuticals is currently trading at Rs. 613.55, up by 0.85 points or 0.14% from its previous closing of Rs. 612.70 on the BSE.
The scrip opened at Rs. 613.00 and has touched a high and low of Rs. 617.70 and Rs. 608.90 respectively. So far 19882 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 615.80 on 15-May-2023 and a 52 week low of Rs. 348.90 on 20-Jun-2022.
Last one week high and low of the scrip stood at Rs. 617.70 and Rs. 550.50 respectively. The current market cap of the company is Rs. 17281.39 crore.
The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 32.90% and 20.45% respectively.
Glenmark Pharmaceuticals has incorporated wholly-owned subsidiary namely - ‘Glenmark Healthcare’ on May 12, 2023. The company has incorporated wholly-owned subsidiary to carry out manufacturing and trading of Pharmaceutical products.
Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.
.jpg)
